Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...
Perampanel is a highly selective, noncompetitive AMPA-type glutamate receptor antagonist currently in development for the treatment of partial seizures in patients with epilepsy. After oral ...
Hosted on MSN2mon
SSY Group’s Drugs Join China’s Reimbursement Listin China’s 2024 National Reimbursement Drug List. Stiripentol, a treatment for severe myoclonic epilepsy in children, is exclusively produced domestically by SSY, while Etomidate is utilized for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback